DAVITA INC. Contract with Customer, Performance Obligation Satisfied in Previous Period
DAVITA INC. (DVA) reported Contract with Customer, Performance Obligation Satisfied in Previous Period of $98.49 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod · last filed 2026-08-04
- DAVITA INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2026-06-30 was $63.01M, a 6.57% decline year-over-year.
- DAVITA INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2026-03-31 was $35.48M, a 24.64% increase year-over-year.
- DAVITA INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2025-12-31 was $67.64M, a 16.76% increase year-over-year.
- DAVITA INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2025-09-30 was $7.83M, a 71.10% decline year-over-year.
- DAVITA INC. contract with customer, performance obligation satisfied in previous period for fiscal 2025 was $171.38M, a 47.32% increase from fiscal 2024.
- DAVITA INC. contract with customer, performance obligation satisfied in previous period for fiscal 2024 was $116.34M, a 23.29% increase from fiscal 2023.
- DAVITA INC. contract with customer, performance obligation satisfied in previous period for fiscal 2023 was $94.36M, a 172.72% increase from fiscal 2022.
- DAVITA INC. contract with customer, performance obligation satisfied in previous period for fiscal 2022 was $34.60M, a 205.87% increase from fiscal 2021.
| Period end | Contract with Customer, Performance Obligation Satisfied in Previous Period 3 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 6 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 9 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | $63.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $98.49M 10-Q · filed 2026-08-04 | $166.13M derived: sum of 3 quarters · filed 2026-08-04 | $173.97M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $35.48M 10-Q · filed 2026-05-05 | $103.12M derived: sum of 2 quarters · filed 2026-05-05 | $110.95M derived: sum of 3 quarters · filed 2026-05-05 | $178.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $67.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $75.47M derived: sum of 2 quarters · filed 2026-02-11 | $142.92M derived: sum of 3 quarters · filed 2026-08-04 | $171.38M 10-K · filed 2026-02-11 |
| 2025-09-30 | $7.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $75.28M derived: sum of 2 quarters · filed 2026-08-04 | $103.74M 10-Q · filed 2025-10-29 | $161.67M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $67.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $95.91M 10-Q · filed 2026-08-04 | $153.84M derived: sum of 3 quarters · filed 2026-08-04 | $180.94M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $28.46M 10-Q · filed 2026-05-05 | $86.40M derived: sum of 2 quarters · filed 2026-05-05 | $113.49M derived: sum of 3 quarters · filed 2026-05-05 | $125.35M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $57.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $85.03M derived: sum of 2 quarters · filed 2026-02-11 | $96.89M derived: sum of 3 quarters · filed 2026-02-11 | $116.34M 10-K · filed 2026-02-11 |
| 2024-09-30 | $27.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $38.95M derived: sum of 2 quarters · filed 2025-10-29 | $58.40M 10-Q · filed 2025-10-29 | $76.81M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $11.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $31.31M 10-Q · filed 2025-08-05 | $49.72M derived: sum of 3 quarters · filed 2026-02-11 | $102.37M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $19.45M 10-Q · filed 2025-05-12 | $37.86M derived: sum of 2 quarters · filed 2026-02-11 | $90.51M derived: sum of 3 quarters · filed 2026-02-11 | $100.99M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $18.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $71.06M derived: sum of 2 quarters · filed 2026-02-11 | $81.54M derived: sum of 3 quarters · filed 2026-02-11 | $94.36M 10-K · filed 2026-02-11 |
| 2023-09-30 | $52.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $63.13M derived: sum of 2 quarters · filed 2024-10-29 | $75.95M 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $10.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $23.30M 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $12.82M 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | $34.60M 10-K · filed 2025-02-13 | |||
| 2021-12-31 | $11.31M 10-K · filed 2024-02-14 | |||
| 2018-03-31 | $67.41M 10-Q · filed 2018-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |